
Ipamorelin and sermorelin both increase your own growth hormone, but they work through different receptors. Sermorelin mimics growth hormone-releasing hormone (GHRH), the body's main signal for growth hormone release. Ipamorelin mimics ghrelin and triggers a clean, selective growth hormone pulse without meaningfully raising cortisol or prolactin.
The short answer: choose sermorelin if you want the gentlest, most natural way to support growth hormone, sleep, and healthy aging. Choose ipamorelin if your priority is recovery, lean muscle, and a stronger growth hormone pulse. Because they act on different receptors, they also work synergistically when taken together.
The main difference is which "on" switch they flip on your pituitary gland. The pituitary has two main receptors that control growth hormone release:
GHRH controls how much growth hormone the pituitary makes and has ready to release. Ghrelin-receptor activation acts as a trigger that releases it, while also suppressing somatostatin, the body's growth hormone brake.
That explains why the two feel different in practice. Sermorelin produces a short, physiologic pulse that closely mirrors the body's own rhythm. Ipamorelin produces a sharper burst of growth hormone that peaks roughly 40 minutes after dosing and fades within a few hours, according to human pharmacokinetic research.
Both peptides follow the same basic path once growth hormone is released:
Neither peptide is growth hormone. Both work upstream, so the body's normal feedback loops stay intact. When growth hormone rises, the hypothalamus releases somatostatin to apply the brakes. This built-in ceiling is a major reason people choose growth hormone peptides over synthetic HGH.
Older ghrelin mimetics such as GHRP-6 and GHRP-2 release growth hormone but also raise cortisol, ACTH, and prolactin, and GHRP-6 in particular causes strong hunger.
Ipamorelin was designed to avoid that. In its original pharmacology study, ipamorelin released growth hormone without significantly raising ACTH or cortisol — even at doses more than 200 times higher than needed for GH release. It also did not affect prolactin, FSH, LH, or TSH. Researchers described it as the first ghrelin-receptor agonist with GH selectivity similar to GHRH itself.
Sermorelin is selective by design, since the GHRH receptor is dedicated to growth hormone release.
Both are popular for sleep, and both are taken at bedtime. The largest natural growth hormone pulse of the day happens shortly after you fall asleep, during deep slow-wave sleep. Taking either peptide before bed amplifies that pulse.
If sleep is your only goal, sermorelin is the gentler starting point. Compare it with other options in our guide to the best peptides for sleep.
Neither peptide is a steroid, and neither builds muscle without training. Both support an anabolic environment by raising growth hormone and IGF-1.
For muscle and recovery, ipamorelin is the more common choice, usually as part of CJC-1295 + Ipamorelin. Learn how that pairing works in our guide to CJC-1295 and ipamorelin, and see more options in our guide to the best peptides for muscle growth.
Neither peptide is a dedicated fat-loss drug, and neither has large trials showing significant weight loss on its own. Both support body composition indirectly through higher growth hormone, which encourages the body to burn stored fat and preserve lean mass.
Ipamorelin's stronger pulse makes it a better fit for body recomposition — losing some fat while building lean muscle — especially when paired with resistance training.
If your main goal is stubborn belly or visceral fat, tesamorelin is the growth hormone peptide with the strongest clinical evidence. For larger overall weight loss, a GLP-1 medication such as tirzepatide is a different, more powerful category. Compare every option in our guide to the best peptides for fat loss.
Growth hormone output falls by roughly 14% per decade after early adulthood, which contributes to slower recovery, thinner skin, more abdominal fat, and less lean mass. Both peptides aim to restore a more youthful growth hormone pattern without the downsides of synthetic HGH.
Sermorelin has the stronger healthy-aging research. In older adults it raised nighttime GH and IGF-1, increased skin thickness in both men and women, and improved well-being and libido in men. Reviews have positioned it as a physiologic approach to adult-onset growth hormone decline because it restores the body's own pulsatile release rather than replacing it.
Ipamorelin has not been studied for aging outcomes in the same way, though it is often included in longevity-focused protocols for its recovery and sleep benefits.
Because ipamorelin works through the ghrelin receptor, some people notice a mild increase in appetite, especially early on. It is far less pronounced than with GHRP-6, which is known for strong hunger. Sermorelin works through the GHRH receptor and does not typically affect appetite.
Ghrelin-receptor activation also increases gut motility. In a phase 2 trial after bowel surgery, ipamorelin was studied specifically for this effect and was well tolerated at the doses tested.
Both peptides raise growth hormone within minutes of an injection, but noticeable changes take longer.
Ipamorelin's stronger pulse may produce noticeable recovery changes slightly sooner, while sermorelin's effects tend to build more gradually.
Both are generally well tolerated, and both can cause injection-site redness, brief flushing, and mild headache.
Any growth hormone peptide can modestly affect fluid retention and blood sugar, so people with diabetes, active cancer, or pituitary conditions should be evaluated by a clinician before starting.
Yes — this is one of the most logical growth hormone stacks. Because sermorelin activates the GHRH receptor and ipamorelin activates the ghrelin receptor, combining them produces a synergistic effect:
This is the same principle behind CJC-1295 with ipamorelin, where CJC-1295 plays the GHRH role. Sermorelin and CJC-1295 are both GHRH analogs; CJC-1295 is longer acting, while sermorelin produces a shorter, more natural pulse.
For body-composition goals, Bowery Clinic's Form blend pairs ipamorelin with tesamorelin, AOD-9604, and MOTS-c.
By contrast, stacking two GHRH peptides such as sermorelin and tesamorelin is generally not recommended, since they compete for the same receptor. Learn more in our guide to tesamorelin vs sermorelin.
Both peptides keep your natural feedback loops intact, which is why they are often preferred over synthetic HGH for adults without diagnosed growth hormone deficiency. Learn more in our guide on how to increase growth hormone.
If you're comparing more than two options, here's how ipamorelin and sermorelin fit alongside the others:
Choose sermorelin if you:
Choose ipamorelin if you:
Choose both if you want a larger growth hormone pulse by targeting the GHRH and ghrelin pathways at the same time.
Generally, yes. Ipamorelin has a longer half-life — about 2 hours versus 10–20 minutes — and produces a sharper growth hormone pulse. Sermorelin produces a gentler pulse that more closely mirrors the body's natural rhythm.
No. Sermorelin is a GHRH analog that works through the GHRH receptor. Ipamorelin is a growth hormone secretagogue that works through the ghrelin receptor. They reach the same outcome — more of your own growth hormone — through different pathways.
Both are taken at bedtime to amplify the body's natural nighttime growth hormone pulse. Sermorelin is the classic choice when sleep is the main goal, while ipamorelin suits people who also want recovery and lean-muscle benefits.
Ipamorelin is more commonly used for muscle recovery and lean-mass goals, especially alongside a GHRH analog such as CJC-1295. Sermorelin has shown modest lean-mass gains in older adults.
Neither is a strong standalone weight-loss treatment. Ipamorelin is a better fit for body recomposition. For stubborn belly fat, tesamorelin has much stronger evidence, and for larger weight loss, GLP-1 medications are more effective.
Yes. Because they act on different receptors, they work synergistically and produce a larger growth hormone pulse together than either does alone.
No. Sermorelin acts only on the GHRH receptor, and ipamorelin's main advantage over older GHRPs is that it releases growth hormone without meaningfully raising cortisol, ACTH, or prolactin.
No. Both stimulate your pituitary rather than replacing its output, so your natural feedback loops stay intact.
Both are usually taken as a small subcutaneous injection at bedtime on an empty stomach, which lines up with the body's largest natural growth hormone pulse during early sleep.
Sermorelin was previously FDA-approved as Geref for growth hormone deficiency in children. It was discontinued in 2008 for business reasons, not safety concerns, and is now available through licensed compounding pharmacies. Ipamorelin has never been FDA-approved.
Ipamorelin and sermorelin both raise your own growth hormone, but through different receptors and for different goals. Sermorelin is the gentle, physiologic option for sleep and healthy aging. Ipamorelin is a selective, stronger option for recovery, lean muscle, and body recomposition. Together, they form a complementary stack that targets both growth hormone pathways at once.
To find out which fits your goals, explore Sermorelin, CJC-1295 + Ipamorelin, or Form at Bowery Clinic.

